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Abstract
Background: The inability of the adult mammalian heart to replace cells lost after severe cardiac injury compromises
organ function. Although the heart is one of the least regenerative organs in the body, evidence accumulated in
recent decades indicates a certain degree of renewal after injury. We have evaluated the role of cardiac Bmi1+
progenitor cells (Bmi1-CPC) following acute myocardial infarction (AMI).
Methods: Bmi1Cre/+;Rosa26YFP/+ (Bmi1-YFP) mice were used for lineage tracing strategy. After tamoxifen (TM) induction,
yellow fluorescent protein (YFP) is expressed under the control of Rosa26 regulatory sequences in Bmi1+ cells. YFP+
cells were tracked following myocardial infarction. Additionally, whole transcriptome analysis of isolated YFP+ cells was
performed in unchallenged hearts and after myocardial infarction.
Results: Deep-sequencing analysis of Bmi1-CPC from unchallenged hearts suggests that this population expresses
high levels of pluripotency markers. Conversely, transcriptome evaluation of Bmi1-CPC following AMI shows a rich
representation of genes related to cell proliferation, movement, and cell cycle. Lineage-tracing studies after cardiac
infarction show that the progeny of Bmi1-expressing cells contribute to de novo cardiomyocytes (CM) (13.8 ± 5 % new
YFP+ CM compared to 4.7 ± 0.9 % in age-paired non-infarcted hearts). However, apical resection of TM-induced day 1
Bmi1-YFP pups indicated a very minor contribution of Bmi1-derived cells to de novo CM.
Conclusions: Cardiac Bmi1 progenitor cells respond to cardiac injury, contributing to the generation of de novo CM in
the adult mouse heart.
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Background
Myocardial infarction leads to an irreversible loss of
cardiac myocytes, which compromises cardiac function.
Although adult mammals are believed to have a very
limited capacity to replace cardiomyocytes (CM), the
traditional view of a terminally differentiated organ has
recently been challenged by evidence of low intrinsic
CM turnover in the adult mouse [1] and human hearts
[2]. Estimated rates of CM turnover nonetheless vary
greatly [3], and the underlying mechanisms [1, 4] and
the origin of new cells contributing to adult cardiomyo-
cyte turnover after injury remain unclear [5]. The main
concepts to explain heart turnover are based on
proliferation of CM [6–8] or the potential of cardiac
progenitor cells (CPC) that are defined primarily by
surface markers such as c-KIT [9] or SCA-1 (also known
as Ly6a) [10, 11]. The diversity of findings for these
populations and the absence of specific, definite markers
to identify CPC have given rise to notable controversy.
Bmi1, a member of the Polycomb repressive complex
1 (PRC1), has a central role during self-renewal and
maintenance of several adult stem cell compartments
[12–14]. High Bmi1 expression defines a population of
adult resident cardiac progenitor cells (Bmi1-CPC) that
are able to generate de novo CM during homeostasis in
the adult heart [15]. Here we show that Bmi1-CPC have
a stemness genetic profile, are activated, and contribute
to de novo CM after acute myocardial infarction (AMI).* Correspondence: abernad@cnb.csic.es
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Methods
Bmi1IRESCreER mice and tamoxifen administration
Males and female double heterozygous Bmi1CreER/+;
Rosa26YFP/+ (Bmi1-YFP) mice, generated by crossing the
Bmi1CreER/+ strain with Rosa26YFP/+ reporter mice, received
intraperitoneal (i.p.) tamoxifen (TM) injections (Sigma)
between postnatal days 30 (P30) and P60. For neonatal
studies, pregnant Bmi1CreER/CreER x Rosa26YFP/YFP
mothers were TM-induced at 17.5 and 18.5 days postcoi-
tum. TM was dissolved in corn oil (Sigma; final concen-
tration 20 mg/ml), and mice received TM every 24 h on
three consecutive days (9 mg/40 g body weight; each day).
The ethics committees of the Spanish Cardiovascular
Research Center (CNIC) and the Spanish National Center
for Biotechnology (CNB) approved the animal studies.
Immunodetection analysis
Heart immunohistochemistry was performed as described
[6]. Specific yellow fluorescent protein (YFP) detection
with anti-green fluorescent protein (GFP) antibody was
confirmed by immunofluorescence analysis of two control
conditions (heart sections from TM-injected Rosa26YFP/+
and non-injected Bmi1-YFP mice (Bmi1-YFPNI)); no signal
was observed in either [15]. For immunodetection, sec-
tions were fixed in 2 % paraformaldehyde (PFA) and
rinsed in PHEM buffer (25 mM Hepes, 10 mM EGTA, 60
mM PIPES, 2 mM MgCl2; all from Sigma). Slides were
rinsed in blocking buffer (0.5 % porcine skin gelatin, 0.1 %
bovine serum albumin (BSA); Sigma) and incubated in
150 mM glycine (Merck; 10 min at room temperature
(RT)), then with sodium borohydride (Sigma; 10 min), and
finally in phosphate-buffered saline (PBS) containing 0.1 %
Triton X-100 (Sigma). Preparations were incubated with
primary antibody (see Additional file 1: Table S1) for 1 h
at RT, washed, and incubated with the appropriate
secondary antibody (1 h). Slides were incubated with
Sytox Green and mounted in ProLong antifade reagent
(both from Invitrogen). Images were captured with a Leica
SP5, Zeiss LSM 700, or LSM 780 coupled to a two-photon
Spectra-Physics Mai.Tai laser scanning confocal micro-
scope, and were assembled with ImageJ (NIH). Processing,
which included pseudo-color assignment and brightness
changes, was applied uniformly across the entire image
and used exclusively to equalize the appearance of mul-
tiple panels in a single figure.
Cell isolation and flow cytometry
Bmi1-YFP hearts were perfused with PBS to remove blood
cells and processed by digestion with 0.1 % collagenase IV
(Sigma) and 10 μg/ml DNAse (Roche) (40 min, 37 °C).
The resulting single cell suspension was passed through a
40-μm filter to remove debris. YFP+ cells were separated
from the total heart mass on a BD FacsAria II cell sorter
fitted with a 488 nm laser to excite YFP (collected in
the 525/50 channel). To discriminate YFP+ from
autoflorescent cells, a 488 nm laser was used to excite
cells, followed by collection in the 585 channel
(phycoerythrin). These peak emission wavelengths are
far enough apart so that each signal can be detected
by a separate detector.
For the Sca-1 population, the CD45+ fraction was re-
moved by discarding CD45+ cells using 405-conjugated rat
anti-CD45 (1:100) and selecting for SCA-1 with APC-rat
anti-SCA-1/Ly6a (1:100; both from BD Pharmingen). Data
were analyzed using Facs DIVA Software.
Isolation of adult mouse cardiomyocytes
Adult mouse CM were isolated from failing hearts of
TM-induced adult Bmi1-YFP mice. The heart was rap-
idly removed and retrograde perfused under constant
pressure (60 mmHg; 37 °C, 8 min) in Ca2+-free buffer
(113 M NaCl, 4.7 mM KCl, 1.2 mM MgSO4, 5.5 mM
glucose, 0.6 mM KH2PO4, 0.6 mM Na2HPO4, 12 mM
NaHCO3, 10 mM KHCO3, 10 mM Hepes, 10 mM
2,3-butanedione monoxime, 30 mM taurine). Digestion
was initiated by adding Liberase Blendzyme recombinant
enzyme mix (0.2 mg/ml; Roche), trypsin (0.14 mg/ml;
Invitrogen), and CaCl2 (12.5 μM) to the perfusion solu-
tion. When the heart became swollen and soft (10 min
digestion) it was removed and gently teased into small
pieces with fine forceps in the same enzyme solution.
Heart tissue was further dissociated using a graded series
of plastic transfer pipettes (2-, 1.5-, and 1-mm diameters
openings) until all large pieces of heart tissue were dis-
persed in a cell suspension. Digestion buffer was neutral-
ized with stopping buffer (10 % fetal bovine serum (FBS),
12.5 μM CaCl2). CM were pelleted by gravity (20 min),
the supernatant aspirated, and CM resuspended in
perfusion solution with 5 % FBS and 12.5 μM CaCl2. The
calcium content was increased by gradual CaCl2 addition
(62 μM to 1 mM). CM were pelleted by gravity (15–
20 min) and, in culture dishes pre-coated with 0.5 g/ml
mouse laminin (BD Biosciences) in PBS (1–2 h, RT), CM
were plated in plating medium (Medium 199 Hank’s
(Invitrogen), 0.25 % BSA (Sigma), 22 mM NaHCO3, 0.05
% FBS (Sigma), 0.001 % ITS Supplement (Gibco), 10 mM
2,3-butanedione monoxime, 25 μM blebbistatin (Sigma))
(2 h); CM were fixed with 2 % PFA and used for immuno-
cytochemistry. In Fig. 4d and e, CM were plated, fixed and
stained for SαA, GFP, and DAPI. The number of YFP+
CM and nuclei were assessed on duplicated microscope
cover glasses (12 mm. diameter). At least 200 CM per
cover glass were counted.
In vivo proliferation analysis
EdU (5-ethynyl-2'-deoxyuridine; Sigma) was dissolved in
0.9 % NaCl solution and stored at 10 mg/ml. For prolif-
eration experiments, mice received EdU (10 μg/g, i.p.,
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once daily, 14 consecutive days). For the homeostatic
group the pulse started on day 6 post-TM induction,
and for the AMI group the pulse was given the day after
AMI (day 6 post-TM induction).
After heart digestion (see above) YFP+ cells were
sorted. For EdU staining, the Click-iT Plus EdU Alexa
Fluor 647 Flow Cytometry reaction (Life Technologies)
was used according to the manufacturer's instructions.
Cell cycle was analyzed by flow cytometry with propi-
dium iodide.
RNA isolation and RNAseq analysis
RNA was extracted from hearts of 8-week-old TM-in-
duced Bmi1-YFP mice. In the homeostatic study at 5
days post-TM induction RNA was extracted from 4 ×
105 sorted Bmi1-CPC (YFP+) and Sca-1-YFP– cells
from four replicates each (6 mice/replicate). Under in-
jury conditions AMI was performed 5 days post-TM
induction, and 5 days post-AMI RNA was extracted
from 4 × 105 sorted Bmi1-CPC (YFP+) cells from four
replicates (2–3 mice/replicate).
Total RNA was isolated with the Arcturus PicoPure
kit (Applied Biosystems). cDNA was amplified from total
RNA (10–25 ng) using the Ovation RNA-seq System v2
(NuGEN Technologies). Amplified cDNA (1 μg) was
sonicated to an average size of 200–300 bp and used
with the TruSeq DNA Sample Preparation v2 Kit
(Illumina) to generate index-tagged sequencing libraries.
Library quality and size distribution were determined
with the Agilent Bioanalyzer DNA-1000 Kit (Agilent
Technologies) and quantified with the Nanoquant spec-
trophotometer (Tecan). Libraries were applied to an
Illumina flow cell for cluster generation (True Seq SR
Cluster Kit V2 cBot). Single reads of 75 bases were gen-
erated on the Genome Analyzer IIx using the TruSeq
SBS Kit v5 (Illumina) following standard sequencing
protocol. Ingenuity Pathway Analysis (IPA) software was
used to integrate RNAseq analysis data to define plaus-
ible signaling cascades by autogenerating regulatory
networks. Gene Ontology (GO) heat maps included sig-
nificant term analysis (adjusted P value <0.05) of genes
differentially expressed in Bmi1-CPC versus Sca-1-YFP–
cardiac compartments. GO analysis of significantly
over- and under-represented terms was conducted with
FatiGO (www.babelomics.org). Heat maps in Fig. 3d
were obtained with Genesis software.
Histology (hematoxylin/eosin staining)
Neonatal hearts from Bmi1-YFP mice at 1, 7, and 21
days post-resection (dpr) were rinsed with PBS, embed-
ded directly in OCT (Tissue Tek), and stored at –80 °C.
Cryosections (8 μm) were hematoxylin/eosin-stained fol-
lowing standard procedures.
Cardiac injury models in neonatal and adult mice
The left ventricular apex was resected in neonatal hearts
from P1 Bmi1-YFP mice. Neonates were anesthetized by
cooling on an ice bed (4 min). Lateral thoracotomy at
the fourth intercostal space was performed by blunt dis-
section of the intercostal muscles following skin incision.
To separate the ribs we used 1-mm wide retractors
(FST) to expose the heart. Iridectomy scissors were used
to resect the P1 heart apex to expose the left ventricular
chamber. Thoracic wall incisions were sutured with 7-0
non-absorbable silk suture, and the skin wound closed
using skin adhesive (Vetbond, 3M). Sham-operated mice
underwent the same procedure without apical resection.
Neonates were then placed under a heat lamp and
warmed for several minutes until recovery.
For AMI in adult hearts, mice were anesthetized with
4 % sevoflurane, intubated, and ventilated with a 50 %
air:oxygen mixture using a positive-pressure respirator
(Minivent 845, Harvard; 160 strokes/min, 250 μl tidal
volume). A left thoracotomy was performed via the
fourth intercostal space and the lungs retracted to ex-
pose the heart. After opening the pericardium, the left
anterior descending coronary artery was ligated with 7-0
silk suture approximately 2 mm below the edge of the
left atrial appendage. Ligation was considered successful
when the anterior wall of the left ventricle turned pale.
The lungs were inflated by increasing positive end-
expiratory pressure and the thoracotomy site closed in
layers with 6-0 suture. Animals were maintained on a
37 °C heating pad until recovery and for 2 h after surgery.
Another group of mice underwent sham ligation, with a
similar surgical procedure without tightening the suture
around the coronary artery.
Statistical analysis
Statistical analysis was performed with GraphPad Prism
5.0. Significance between groups was evaluated in all ex-
periments as detailed for each figure. A value of P < 0.05
was considered significant. All replicates considered are
biological replicates. P values were calculated by un-
paired Student’s t test with Welch’s correction. Data are
shown as mean ± SEM.
Results
Transcriptome study of Bmi1-CPC isolated from
unchallenged hearts shows enrichment in
stemness-related genes
We previously reported that non-myocyte Bmi1-CPC
contribute to homeostatic cardiomyocyte turnover in the
adult murine heart [15]. Following TM induction of
healthy Bmi1CreER/+;Rosa26YFP/+ mice (Bmi1-YFP), flow
cytometry of non-cardiomyocyte heart cells identified a
YFP-expressing population (2.7 ± 0.2 % cells/heart) 5
days post-TM induction that represents a small subset
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(5.4 ± 0.4 %) of the SCA-1+ cardiac population [15].
Additionally, lineage tracing of Bmi1+-derived progeny
up to 1 year after TM induction showed YFP+ CM
(6.7 ± 1.3 %) in vivo.
To define the Bmi1-CPC genetic profile more pre-
cisely, we conducted a comparative RNAseq analysis of
Bmi1-CPC (YFP+) and Sca-1+, YFP-negative reference
(Sca-1-YFP–) cell populations sorted from hearts of 6- to
8-week-old Bmi1-YFP mice 5 days post-TM induction.
Heat map analysis differentiated the two populations
and defined precise profiles for each (Fig. 1a). Of a total
of 37,686 transcripts processed, 4555 (12 %) were
differentially expressed between the Bmi1-CPC and
Sca-1-YFP– populations (Fig. 1b). GO analysis showed
high representation of genes related to immunity, circula-
tion, and muscle contraction in the Bmi1-CPC (Fig. 1c).
The Bmi1-CPC expression profile overlapped with other
stem cell systems, including expression of critical embry-
onic and adult multipotent markers (Pou5f1, Suz12,
Dppa5, Prom1) (Fig. 1d) which was not shared by the
Sca-1-YFP– cells. The Notch pathway, which is implicated
in cardiac development, was upregulated in the
Bmi1-CPC compartment (Fig. 1e). Additionally, IPA
of upstream regulators in the Bmi1-CPC population
predicted enrichment for functions related to stemness
(Sox2, Klf2) and cardiac development (Srf, Myocd, Tbx5)
(Fig. 1f). Conversely, the main upstream regulators pre-
dicted by IPA in the Sca-1-YFP– population were growth
factors (Fig. 1g). These findings suggest that Bmi1-CPC
have the potential to contribute to cardiac fate while
remaining competent for self-maintenance.
Bmi1-CPC are activated in response to acute myocardial
infarction
To evaluate the Bmi1-CPC-mediated response after
heart injury, we conducted lineage-tracing analysis in
adult Bmi1-YFP mice (8–12 weeks old) that underwent
AMI at 5 days post-TM induction. Bmi1-CPC-derived
progeny (YFP+ cells) were traced after Cre-mediated re-
combination of the responder cassette in Bmi1-YFP mice
(Fig. 2a). Five days after AMI, the number of YFP+ cells
isolated from injured Bmi1-YFP mouse hearts was sig-
nificantly larger (≈1.5-fold) than in healthy (homeostatic)
littermates (Fig. 2b). This finding was supported by in
vivo pulse-chase EdU labeling of YFP+ cells, which com-
pared physiological and AMI conditions. The YFP+
population had a higher proliferation rate (≈2-fold) after
AMI (Fig. 2c). Immunohistochemistry of heart sections
at 15 days post-AMI detected YFP+ clusters in niche-like
structures near and within the infarcted zone (Fig. 2d).
Cardiac injury induces an activated phenotype in Bmi1-CPC
To evaluate the changes in mRNA transcript levels in
adult Bmi1-CPC after severe cardiac injury, we induced
AMI in adult Bmi1-YFP mice (6 to 8 weeks old) 5 days
post-TM induction. YFP+ cells were isolated from hearts
at 5 days post-AMI and the transcriptome analyzed by
RNAseq. In comparison with Bmi1-CPC isolated from
control, non-infarcted Bmi1-YFP mice, the analysis
showed differential expression of more than 5500 genes;
heat map analysis neatly differentiated the two conditions
(Fig. 3a). IPA showed post-injury upregulation of genes re-
lated to cell growth and proliferation (1574 genes), cell
death and survival (1533), cell movement (1001), and cell
cycle (727) (Fig. 3b). This activation was accompanied by
clear dysregulation of several multipotency markers such
as Dppa5 and Pou5f1, as well as genes related to muscle
contractility and calcium management (Pnpla2, Myh6)
(Fig. 3c). Key transcripts involved in pathways such as cell
proliferation, movement, and cell cycle were significantly
upregulated in Bmi1-derived cells 5 days post-AMI
(Fig. 3d). Bmi1-CPC after AMI also showed marked
upregulation of extracellular matrix and several growth
factors, and pro- and anti-inflammatory cytokines were
also notably upregulated (Fig. 3d).
These results suggest a proliferative activation of
Bmi1-derived cells shortly after AMI, and the upregula-
tion of crucial cell functions that are required to respond
after tissue injury and instigate repair.
Bmi1-CPC contribute to cardiac repair with de novo
cardiomyocytes after myocardial infarction in adult mice
but not after neonatal apical heart resection
To evaluate the response of Bmi1+-derived cells at late
stages of cardiac injury, we traced the progeny of Bmi1-
CPC at 3 months post-AMI. Although YFP+ clusters were
virtually undetectable in the infarcted zone (Fig. 4a), im-
munohistochemical analysis found YFP+ CM (as deter-
mined by the marker sarcomeric α-actinin (SαA)) located
predominantly at the infarct border and in remote zones
(Fig. 4b), but not in the area of injury. Immunostaining for
a panel of contractility-related proteins including cardiac
troponin T, SαA, and the gap junction protein, connexin
43, in isolated CM 4 months post-AMI showed that
YFP+ CM were indistinguishable from YFP– CM (Fig. 4c).
We also assessed the number of YFP+ CM isolated from
Bmi1-YFP mice at 4 months post-AMI; these cells made
up 13.8 ± 5 % of total CM compared to 4.7 ± 0.9 % in age-
paired non-infarcted hearts (Fig. 4d). YFP+ CM exhibit the
same nucleation pattern as the YFP– CM (Fig. 4e), which
are mainly binucleated (80 %). These data reinforce the
hypothesis that Bmi1-CPC are a reservoir of adult cardiac
progenitor cells able to respond to acute injury with de
novo generation of CM.
Additionally, the relevant regenerative capacity that
the mouse neonatal heart exhibits during the first week
of life has been recently reported [16, 17]. Therefore, we
next explored the potential role of Bmi1-CPC in these





Fig. 1 Bmi1-CPC have a stemness profile and upstream regulators related to cardiac development and pluripotency. a Heat map of matched
samples (n = 4 replicates; 6 mice/replicate) in high-throughput RNAseq analysis of Bmi1-CPC and Sca-1-YFP– cells. b RNAseq gene summary. c Gene
Ontology (GO) heat map including significant terms analysis (adjusted P < 0.05) of genes differentially expressed in Bmi1-CPC versus Sca-1-YFP–
compartments. GO analysis of significantly over- and under-represented terms with FatiGO. d Pluripotency pathway analysis. Comparative expression
of stemness-related genes. Red indicates significant overexpression in Bmi1-CPC and green significant overexpression in Sca-1-YFP– populations.
Numbers in red represent logarithmic fold change (log FC). e IPA analysis of the Notch pathway in Bmi1-CPC versus Sca-1-YFP– populations. Red indicates
significant overexpression in Bmi1-CPC and green significant overexpression in Sca-1-YFP– populations. Numbers in red represent log FC. f IPA prediction
for main upstream regulators in the Bmi1-CPC population. g IPA prediction for main upstream regulators in the Sca-1-YFP– population
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early cardiac stages (Fig. 4f ). We treated pregnant mice
(Bmi1CreER/CreER or Rosa26YFP/YFP females) with TM
(E17.5, E18.5); flow cytometry confirmed YFP expression
in neonatal heart cells (double heterozygotes) at postna-
tal day 1 (P1) (Fig. 4g). Bmi1-YFP pups that underwent
apex resection at P1 were sacrificed at P21, when the
apex was fully restored (Fig. 4h). YFP+ cells were de-
tected in the atrium and ventricle, but very rarely or not
at all in the regenerated area (Fig. 4i); this indicates that
Bmi1-derived cells make no major contribution to
immediate postnatal regeneration.
Discussion
Our study provides evidence that Bmi1-derived cells
contribute to de novo generation of CM after myocardial
infarction, which is greater than for heart homeostasis
with ageing. These findings consolidate Bmi1-CPC cells
as a sound source of progenitors for cardiac repair.
The cardiac stem field was initiated by the isolation
and characterization of c-KIT+ CPC [9], which recently
were proposed necessary and sufficient for heart repair
after injury [18]. c-kit expression in vitro and in vivo has
yielded disparate results, however, which probably re-
flects the extremely variable expression of this marker in
distinct contexts and conditions [19, 20]. Three recent
independent lineage-tracing studies found that c-kit+
cardiac progenitor cells produce <0.008 % of the new
CM in adult mouse heart, and proposed that c-kit+ cells
are not relevant either for homeostasis or after myocar-
dial infarction [21–23]. Our own research on Bmi1-CPC
showed that these progenitors are mainly negative for
c-KIT expression (0.1–1 %) [15], suggesting that the
Fig. 2 Activation of Bmi1-CPC after acute myocardial infarction. a Timeline for analysis of Bmi1-CPC cells and progeny. b Number of YFP+ cells
obtained by FACS sorting 5 days post-acute myocardial infarction (AMI; n = 9) compared to the uninjured heart (homeostatic) condition (n = 15).
**P < 0.01. Data shown as mean ± SEM. c Cell cycle study of freshly isolated YFP+ cells after EdU administration to Bmi1-YFP mice in physiological
(homeostasis; top) and post-AMI conditions (bottom) (n = 4). *P < 0.05, **P < 0.01. d Partial transverse section of an injured Bmi1-YFP left ventricle
15 days post-AMI (left) and detailed YFP+ clusters located in the infarcted area (right). Scale bars = 200 μm (left), 50 μm (right panels)
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majority of de novo CM derive from Bmi1+ c-kit–
progeny.
Putative CPC have also been isolated based on their
expression of the established hematopoietic marker
SCA-1 [24], although SCA-1 appears to label a heteroge-
neous population with predominantly endothelial poten-
tial [25, 26]. Genetic elimination of Sca-1 affects resident
CPC, which then fail to respond to pathological damage
in vivo; this coincided with impaired in vitro growth and
survival of these cardiac progenitor cells [27]. SCA-1
CPC contributes to CM generation in a model of pres-
sure overload cardiac injury (transverse aortic constric-
tion), but not after AMI [24]. Our Bmi1-CPC showed a
strong response after AMI and the percentage of de
novo CM generated is greater than that observed during
normal cardiac homeostasis. Although Uchida et al. [24]
found no major contribution by the Sca-1+ population
in new CM formation after acute injury, the distinct
methods and transgenic models used in these studies
could explain the differences. The authors nonetheless
suggested that only a small fraction of the Sca-1+ popu-
lation contributes to the CM lineage [24]. Bmi1-CPC
make up a fraction of the Sca-1+ population [15], and
our results here suggest that Bmi1+ cells are the Sca-1+
subset involved in this new CM generation. The infor-
mation gleaned from the deep-sequencing analysis of
Bmi1-CPC from healthy hearts reinforces the idea that
this population expresses higher levels of pluripotency
markers. We consider Bmi1 to be a key transcription
factor that controls stemness in the adult heart, thus de-
fining a population of cardiac progenitors. This would
be in agreement with the critical positive role of Bmi1 in
fibroblast reprogramming to embryonic stem cells [28,
29] and the very recent description as a key epigenetic
barrier to direct cardiac reprogramming [30].
The limited capacity of the adult mammalian heart to
recover after myocardial injury is well established. A
genetic fate-mapping strategy gave indirect evidence that
up to 19 % of CM are replaced 3 months post-AMI, but
the source of the new CM was not definitively deter-
mined [31]. Our lineage-tracing studies after cardiac
infarction show that Bmi1-expressing cells contribute to
significant and comparable numbers of de novo CM.
This result provides direct evidence of a resident cardiac
progenitor population that contributes to heart repair.
RNAseq analysis of Bmi1-CPC isolated 5 days after AMI
showed an increase in genes related to cell proliferation,
movement, and cell cycle functions, all of which are
necessary for cells to reach the infarcted area and to
instigate repair. Bmi1-derived cells also showed marked
upregulation of extracellular matrix proteins, growth fac-
tors, and pro- and anti-inflammatory cytokines. The data
from the RNAseq study indicate that, following cardiac
injury, Bmi1-CPC sense the unfavorable environment
originated by the insult and respond by upregulating
pathways related to key cell functions required to
promote repair. Although we did not detect a defined
pattern of cardiomyocyte specification markers in the
Bmi1-derived cells 5 days after injury, surviving Bmi1-
CPC at this early stage might need to proliferate and
migrate before they can respond appropriately to injury-
induced signals. Lineage tracing of Bmi1+ cells at 4
months post-AMI showed generation of 13.8 ± 5 % new
YFP+ CM, which coincides with some previous reports
[31] and pinpointed the Bmi1-CPC ability to contribute
to myocardial repair after injury. Immunostaining of a
panel of contractility-related proteins showed that these
YFP+ CM were indistinguishable from YFP– CM. Al-
though we did not detect YFP+ CM within the injured
area, these new CM might have an important role in
supporting basal heart beat and cardiac function after
AMI. In any case, the role of Bmi1+-CPC in cardiac re-
pair after AMI is compatible with contributions from
other reported sources [24, 32]. Further characterization
of the mechanisms that lead to endogenous progenitor
cell activation and of the mechanisms that permit re-
population of the infarcted region could be a new oppor-
tunity for therapeutic applications.
Although the adult mammalian heart is one of the least
regenerative organs in the body, different studies have
described heart regeneration in lower vertebrates and
neonatal mammals following apical resection [33, 34].
Lineage tracing experiments in adult zebrafish following
cardiac injury suggest that the vast majority of the regen-
erated CM are derived from pre-existing proliferative CM
rather than from a population of cardiac stem/progenitor
cells [34, 35]. Additionally, the neonatal mouse heart has
shown a similar ability to restore the lost myocardial tissue
(See figure on previous page.)
Fig. 3 Bmi1-CPC upregulate pathways related to proliferation and cell motility and downregulate some pluripotent genes after cardiac injury.
a Heat map of matched samples (n = 4 replicates, 2–3 mice/replicate) in the high-throughput RNAseq analysis of sorted Bmi1-CPC (YFP+) cells
from adult TM-induced control mice (non-infarcted) and mice subjected to acute myocardial infarction (AMI) at 5 days post-treatment. b Heat
map of molecular and cellular functions in Bmi1-CPC 5 days post-AMI, compared to counterparts from non-infarcted hearts, and classified by
activation z-score. c Differential expression of genes implicated in pluripotency and muscle contractility and calcium management. Genes are
classified as down- (red) and upregulated (blue) in sorted Bmi1-CPC 5 days post-AMI by comparison with Bmi1-CPC counterparts from non-infarcted
hearts. d Heat map of proliferation and cell migration functions and genes related to the extracellular compartment, immunomodulation, cytokines,
chemokines, and growth factors in sorted Bmi1-CPC 5 days post-AMI by comparison with Bmi1-CPC counterparts from non-infarcted hearts. Color scale
intensity is related to gene log fold change (FC)
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Fig. 4 (See legend on next page.)
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within the first week of postnatal life [17, 36, 37], primar-
ily, by proliferation of pre-existing cardiomyocytes and
not by putative population(s) of endogenous CPC [38, 39].
However, the ability to efficiently regenerate the heart
muscle upon injury is essentially lost by postnatal day 7,
coinciding with the developmental window when mouse
CM mostly binucleate and withdraw from the cell cycle
[40]. This compromised ability to fully repair the dam-
aged/resected myocardium is mainly related to the lack of
basal proliferation in adult CM. However, there are several
reports pinpointing the relevant role of endogenous CPC
leading to the reparative response in the adult mouse fol-
lowing cardiac injury [24, 31, 32, 41]. Although adult CPC
do not fully restore a severe acutely damaged tissue, their
contribution to de novo CM may contribute to maintain
organ functionality. Altogether these reports, and our own
data (apical resection of TM-induced day 1 Bmi1-YFP
pups indicate a minor contribution of Bmi1-derived cells
to de novo CM), may suggest a switch in CPC reparative
role through the lifespan of the organism.
Therefore, further studies will determine and evaluate
the mechanisms by which Bmi1+ cells remain less active
in neonatal heart regeneration but play a more direct role
in adult heart repair. Moreover, it will also be necessary to
understand the hypothetic crosstalk existing between CM
and Bmi1+ through the lifespan of the animal to clarify
the different reparative responses that Bmi1+ exhibit fol-
lowing cardiac injury in the neonatal and adult heart.
Conclusions
Our results show that Bmi1 expression defines a multi-
potent cardiac cell population with capacity for myocar-
dial repair following cardiac injury in adult mice. Future
research to better characterize the biology of Bmi1-CPC
will help to identify critical factors that allow their po-
tential to be harnessed for effective cardiac cell therapy.
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Fig. 4 Bmi1-CPC response to acute injury in adult and neonatal mouse hearts. a Detailed transverse section of Bmi1-YFP left ventricle 3 months
post-acute myocardial infarction (AMI). Scale bar = 200 μm. b YFP+ cardiomyocytes (CM) 3 months post-AMI, located near the injured area (left)
and at sites distant from the infarcted zone (right); (n = 3). Dotted line delineates the border of the injured area. Arrows indicate YFP+ CM. Scale
bars = 50 μm. c Adult CM freshly isolated 4 months post-AMI. YFP+ CM express cardiac proteins related to contractility and gap junctions, including
sarcomeric α-actinin (SαA), (cardiac troponin T (cTnT), and connexin 43 (CX43). Scale bars= 50 μm. d Number of YFP+ CM in adult mice (4 months post-
AMI, n = 4) compared with the number in non-infarcted hearts (homeostasis; 4 months post-AMI, n = 4). *P < 0.05. Data shown as mean ± SEM. CM
were plated, fixed, and stained for SαA, GFP, and DAPI. The number of YFP+ CM was assessed in duplicated microscope cover glasses (12 mn diameter).
At least 200 CM per cover glass were counted. e Nucleation of YFP+ CM in homeostasis and after AMI (n = 3-4 mice). Data shown as mean ± SEM. CM
were isolated 4 months post-AMI, plated, fixed and stained for SαA, GFP and DAPI. Nucleation of YFP+ CM was assessed in duplicated microscope
cover glass (12 mm diameter). At least 200 CM per cover glass were counted. f Schematic representation of apical resection experiments on tamoxifen
(TM)-induced neonatal hearts. g YFP+ fraction in postnatal day 1 (P1) Bmi1-YFP hearts accounts for 0.3 ± 0.04 % of total mononuclear heart cells (n = 8).
YFP+ cells were not detected in non-induced controls (Bmi1-YFPNI, inset). Data shown as mean ± SEM. h Hematoxylin/eosin staining of mouse heart at
1, 7, and 21 days post-apical resection (dpr) in neonatal (P1) mouse pups. Dashed line delineates the resection plane. Enlarged view of resected areas is
shown, delimited by dashed squares. Scale bars= 1000 μm. i Immunodetection of YFP+ clusters (arrows) near the injured area (left and center) and
atrium (right) 21 days after neonatal heart apical resection (n = 3). Dashed line delimits the regenerated apex 21 dpr. Scale bars= 50 μm (left, right), and
20 μm (center)
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